Arvinas Inc.
Clinical trials sponsored by Arvinas Inc., explained in plain language.
-
First pill of its kind tested to fight Tough-to-Treat lymphoma
Disease control Recruiting nowThis is the first study to test a new oral drug called ARV-393 in people. It aims to see if the drug is safe and if it can help control advanced non-Hodgkin's lymphoma that has come back or stopped responding to other treatments. The drug is designed to break down a specific prot…
Phase: PHASE1 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug targets 'Undruggable' cancer mutation in first human trial
Disease control Recruiting nowThis is the first study to test a new drug called ARV-806 in people with advanced solid tumors that have a specific KRAS G12D mutation. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that it can shrink tumors. Th…
Phase: PHASE1, PHASE2 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC